Back to today’s briefing

Story perspectives

FDA Warns of Counterfeit Ozempic Threatening Patient Safety

4/16/2025

34 6

Summary

Story summary

The FDA has issued a stark warning about counterfeit Ozempic (semaglutide) infiltrating the U.S. drug supply. Seized on April 9, these deceptive vials bear a legitimate lot number (PAR0362) but sport fraudulent serial numbers beginning with 51746517. Patients and healthcare providers are strongly urged to double-check prescriptions to safeguard their health.

1 of 1

Story summary

The FDA has issued a stark warning about counterfeit Ozempic (semaglutide) infiltrating the U.S. drug supply. Seized on April 9, these deceptive vials bear a legitimate lot number (PAR0362) but sport fraudulent serial numbers beginning with 51746517. Patients and healthcare providers are strongly urged to double-check prescriptions to safeguard their health.